Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Allergic contact dermatitis (ACD) is a common inflammatory skin disorder and an alternative form of contact dermatitis. It is manifestation of allergic responses caused by the contact of an allergic substance such as, nickel, gold, chromium, mercaptobenzothiazole, formaldehyde and many more. The other form of contact dermatitis is irritant contact dermatitis (ICD). Symptoms of allergic contact dermatitis (ACDs) are similar to that of irritant contact dermatitis, which makes the diagnosis harder. The symptoms of allergic contact dermatitis include presence of the skin lesion or rashes at the exposure site. Depending on the allergen type, it may form blisters, papules, simple red spots, vesicles and rashes. The rash can drain, ooze or crust and also becomes raw, thickened or scaled. Allergic contact dermatitis (ACD) is caused as a result of two stages, first stage sensitize and primes the immune system for allergic responses and the second stage, triggers it. The diagnosis of allergic contact dermatitis includes physical examination and medical therapy. The precise diagnosis based on the symptoms and by rash appearance is very rare. The intermittent or chronic rashes that are not clarified by historical data and physical examination often requires further testing. A patch test (contact delayed hypersensitivity allergy test) is a normally used to detect the actual cause of allergic contact dermatitis.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Allergic Contact Dermatitis (ACDS) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Allergic Contact Dermatitis (ACDS) market. Detailed analysis of key players, along with key growth strategies adopted by Allergic Contact Dermatitis (ACDS) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Taro Pharmaceuticals
Glenmark Pharmaceuticals
RENHE
Boiron
Sandoz
Pannoc
Teva Pharmaceuticals
Perrigo
Sanofi
By Type:
Glucocorticoids
Topical Steroids
Miscellaneous Topical Agents
Corticosteroid
Anticholinergic Antiemetic
Miscellaneous Anxiolytics, Sedatives and Hypnotics
By End-User:
Topical Administration
Oral Administration
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Allergic Contact Dermatitis (ACDS) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Glucocorticoids from 2016 to 2027
-
1.3.2 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Topical Steroids from 2016 to 2027
-
1.3.3 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Miscellaneous Topical Agents from 2016 to 2027
-
1.3.4 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Corticosteroid from 2016 to 2027
-
1.3.5 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Anticholinergic Antiemetic from 2016 to 2027
-
1.3.6 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Miscellaneous Anxiolytics, Sedatives and Hypnotics from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Topical Administration from 2016 to 2027
-
1.4.2 USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Oral Administration from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Allergic Contact Dermatitis (ACDS) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Allergic Contact Dermatitis (ACDS) by Major Types
-
3.4.1 Market Size and Growth Rate of Glucocorticoids
-
3.4.2 Market Size and Growth Rate of Topical Steroids
-
3.4.3 Market Size and Growth Rate of Miscellaneous Topical Agents
-
3.4.4 Market Size and Growth Rate of Corticosteroid
-
3.4.5 Market Size and Growth Rate of Anticholinergic Antiemetic
-
3.4.6 Market Size and Growth Rate of Miscellaneous Anxiolytics, Sedatives and Hypnotics
4 Segmentation of Allergic Contact Dermatitis (ACDS) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Allergic Contact Dermatitis (ACDS) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Allergic Contact Dermatitis (ACDS) in Topical Administration
-
4.4.2 Market Size and Growth Rate of Allergic Contact Dermatitis (ACDS) in Oral Administration
5 Market Analysis by Regions
-
5.1 USA Allergic Contact Dermatitis (ACDS) Production Analysis by Regions
-
5.2 USA Allergic Contact Dermatitis (ACDS) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis
-
6.1 West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major Types
-
6.2 West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major End-Users
7 South USA Allergic Contact Dermatitis (ACDS) Landscape Analysis
-
7.1 South USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major Types
-
7.2 South USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major End-Users
8 Middle West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis
-
8.1 Middle West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major Types
-
8.2 Middle West USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major End-Users
9 Northeast USA Allergic Contact Dermatitis (ACDS) Landscape Analysis
-
9.1 Northeast USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major Types
-
9.2 Northeast USA Allergic Contact Dermatitis (ACDS) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Taro Pharmaceuticals
-
10.1.1 Taro Pharmaceuticals Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Glenmark Pharmaceuticals
-
10.2.1 Glenmark Pharmaceuticals Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 RENHE
-
10.3.1 RENHE Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Boiron
-
10.4.1 Boiron Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sandoz
-
10.5.1 Sandoz Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Pannoc
-
10.6.1 Pannoc Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Teva Pharmaceuticals
-
10.7.1 Teva Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Perrigo
-
10.8.1 Perrigo Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Sanofi
-
10.9.1 Sanofi Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Glucocorticoids from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Topical Steroids from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Miscellaneous Topical Agents from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Corticosteroid from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Anticholinergic Antiemetic from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Miscellaneous Anxiolytics, Sedatives and Hypnotics from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Topical Administration from 2016 to 2027
-
Figure USA Allergic Contact Dermatitis (ACDS) Market Size and Growth Rate of Oral Administration from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Allergic Contact Dermatitis (ACDS) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Allergic Contact Dermatitis (ACDS)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Allergic Contact Dermatitis (ACDS) by Different Types from 2016 to 2027
-
Table Consumption Share of Allergic Contact Dermatitis (ACDS) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Glucocorticoids
-
Figure Market Size and Growth Rate of Topical Steroids
-
Figure Market Size and Growth Rate of Miscellaneous Topical Agents
-
Figure Market Size and Growth Rate of Corticosteroid
-
Figure Market Size and Growth Rate of Anticholinergic Antiemetic
-
Figure Market Size and Growth Rate of Miscellaneous Anxiolytics, Sedatives and Hypnotics
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Allergic Contact Dermatitis (ACDS) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Allergic Contact Dermatitis (ACDS) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Topical Administration
-
Figure Market Size and Growth Rate of Oral Administration
-
Table USA Allergic Contact Dermatitis (ACDS) Production by Regions
-
Table USA Allergic Contact Dermatitis (ACDS) Production Share by Regions
-
Figure USA Allergic Contact Dermatitis (ACDS) Production Share by Regions in 2016
-
Figure USA Allergic Contact Dermatitis (ACDS) Production Share by Regions in 2021
-
Figure USA Allergic Contact Dermatitis (ACDS) Production Share by Regions in 2027
-
Table USA Allergic Contact Dermatitis (ACDS) Consumption by Regions
-
Table USA Allergic Contact Dermatitis (ACDS) Consumption Share by Regions
-
Figure USA Allergic Contact Dermatitis (ACDS) Consumption Share by Regions in 2016
-
Figure USA Allergic Contact Dermatitis (ACDS) Consumption Share by Regions in 2021
-
Figure USA Allergic Contact Dermatitis (ACDS) Consumption Share by Regions in 2027
-
Table West USA Allergic Contact Dermatitis (ACDS) Consumption by Types from 2016 to 2027
-
Table West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types from 2016 to 2027
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2016
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2021
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2027
-
Table West USA Allergic Contact Dermatitis (ACDS) Consumption by End-Users from 2016 to 2027
-
Table West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2016
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2021
-
Figure West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2027
-
Table South USA Allergic Contact Dermatitis (ACDS) Consumption by Types from 2016 to 2027
-
Table South USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types from 2016 to 2027
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2016
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2021
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2027
-
Table South USA Allergic Contact Dermatitis (ACDS) Consumption by End-Users from 2016 to 2027
-
Table South USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2016
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2021
-
Figure South USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2027
-
Table Middle West USA Allergic Contact Dermatitis (ACDS) Consumption by Types from 2016 to 2027
-
Table Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2016
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2021
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2027
-
Table Middle West USA Allergic Contact Dermatitis (ACDS) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2016
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2021
-
Figure Middle West USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2027
-
Table Northeast USA Allergic Contact Dermatitis (ACDS) Consumption by Types from 2016 to 2027
-
Table Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2016
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2021
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by Types in 2027
-
Table Northeast USA Allergic Contact Dermatitis (ACDS) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2016
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2021
-
Figure Northeast USA Allergic Contact Dermatitis (ACDS) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Taro Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Taro Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Taro Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Taro Pharmaceuticals
-
Table Product and Service Introduction of Taro Pharmaceuticals
-
Table Company Profile and Development Status of Glenmark Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Glenmark Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Glenmark Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Glenmark Pharmaceuticals
-
Table Product and Service Introduction of Glenmark Pharmaceuticals
-
Table Company Profile and Development Status of RENHE
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RENHE
-
Figure Sales and Growth Rate Analysis of RENHE
-
Figure Revenue and Market Share Analysis of RENHE
-
Table Product and Service Introduction of RENHE
-
Table Company Profile and Development Status of Boiron
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boiron
-
Figure Sales and Growth Rate Analysis of Boiron
-
Figure Revenue and Market Share Analysis of Boiron
-
Table Product and Service Introduction of Boiron
-
Table Company Profile and Development Status of Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
-
Figure Sales and Growth Rate Analysis of Sandoz
-
Figure Revenue and Market Share Analysis of Sandoz
-
Table Product and Service Introduction of Sandoz
-
Table Company Profile and Development Status of Pannoc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pannoc
-
Figure Sales and Growth Rate Analysis of Pannoc
-
Figure Revenue and Market Share Analysis of Pannoc
-
Table Product and Service Introduction of Pannoc
-
Table Company Profile and Development Status of Teva Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Teva Pharmaceuticals
-
Table Product and Service Introduction of Teva Pharmaceuticals
-
Table Company Profile and Development Status of Perrigo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo
-
Figure Sales and Growth Rate Analysis of Perrigo
-
Figure Revenue and Market Share Analysis of Perrigo
-
Table Product and Service Introduction of Perrigo
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
